To investigate whether the protection of phagocytosis conferred by downregulating CD24 could be recapitulated in vivo, we treated mice bearing periosteal osteosarcoma with cholesterol-modified Cd24a siRNA or scramble siRNA at a dose of 1 OD every two days through intratumor injection. This evidence concerns the gene CD24 and osteosarcoma.